Blue Sail Medical completes acquisition of Swiss TAVR company NVT AG for RMB 1.39B

Blue Sail Medical completed the acquisition of 100% equity in NVT AG, a Swiss interventional aortic valve company, for RMB 1.39 billion. The closing date was June 8, 2020.

“the acquisition of 100% equity interest in NVT AG for RMB 1.39 billion has been successfully completed.”vcbeathealth.com

• 1 source
• vcbeathealth.comBluesail Medical Successfully Acquires Swiss TAVR Company NVT AG for RMB 1.39 Billion-VCBeatJun 9, 2020

Summarized from public sources; check the original articles before acting on it.